Myanmar vs Tuvalu: Hepatitis B surface antigen (HBsAg) prevalence
Myanmar
1.3%
in 2024
Tuvalu
1.1%
in 2024
Myanmar rank
24th
Tuvalu rank
26th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Myanmar
- Tuvalu
How they compare
Myanmar currently reports 1.3% against 1.1% in Tuvalu, a difference of 0.2%.
That makes Myanmar's figure about 1.2 times Tuvalu's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Myanmar ahead.
Myanmar ranks 24th and Tuvalu ranks 26th of 194 countries.
Tuvalu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Myanmar | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.3% | 1.3% | 0.0% | — |
| 2020s | 1.1% | 1.2% | 0.1% | Tuvalu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Myanmar or Tuvalu?
- Myanmar, at 1.3% against 1.1% in Tuvalu as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Myanmar and Tuvalu?
- 0.2%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Tuvalu?
- 10 years are reported by both, from 2015 to 2024.
- How do Myanmar and Tuvalu rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Myanmar ranks 24th and Tuvalu ranks 26th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.